MedTrace Logo

Validation of a Smartphone-based Recorder for Detection of Cardiac Arrhythmias

NCT03996954 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2020-09-16

No results posted yet for this study

Summary

The investigators will evaluate the diagnostic yield of the new AliveCor device versus a 12 lead ECG when used simultaneously to detect cardiac arrhythmia

Conditions

  • Cardiac Arrhythmia

Interventions

DEVICE

Alivecor recording

Alivecor recording and ECG recording from the same patient in very close temporal proximity

Sponsors & Collaborators

  • Blackpool Teaching Hospitals NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Khalid Abozguia, Ph.D. · Blackpool Teaching Hospitals NHS Foundation Trust

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-08
Primary Completion
2020-10-07
Completion
2020-10-07
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03996954 on ClinicalTrials.gov